Changes in Gut Microbiota and Metabolites in Papillary Thyroid Carcinoma Patients Following Radioactive Iodine Therapy

Changes in Gut Microbiota and Metabolites in Papillary Thyroid Carcinoma Patients Following Radioactive Iodine Therapy

Wanting Li,1,&ast; Feng Cheng,1,&ast; Jun Zhang,1 Caihong Li,2 Daijing Yu,1 Halimureti Simayijiang,1 Haiyan Liu,2 Sijin Li,2 Jiangwei Yan1 1Shanxi Key Laboratory of Forensic Medicine, Shanxi Medical University, Jinzhong, People’s Republic of China; 2Department of Nuclear Medicine, First Hosp...

Full description

Bibliographic Details
Main Authors:	Li W, Cheng F, Zhang J, Li C, Yu D, Simayijiang H, Liu H, Li S, Yan J
Format:	Article
Language:	English
Published:	Dove Medical Press 2023-10-01
Series:	International Journal of General Medicine
Subjects:	radioactive iodine gut microbiota escherichia-shigella metabolism thyroid carcinoma
Online Access:	https://www.dovepress.com/changes-in-gut-microbiota-and-metabolites-in-papillary-thyroid-carcino-peer-reviewed-fulltext-article-IJGM

Similar Items

Acute myeloid leukemia following radioactive iodine therapy for papillary carcinoma of the thyroid
by: Jain Ankit, et al.
Published: (2009-06-01)

Risk factors and clinical characteristics associated with post-radioactive iodine thyroid storm
by: Harold Henrison C. Chiu, et al.
Published: (2024-12-01)

Radioactive iodine in low- to intermediate-risk papillary thyroid cancer
by: Hengqiang Zhao, et al.
Published: (2022-08-01)

The Efficacy of Low-Iodine Diet Instructional Media for the Preparation of Radioactive Iodine Therapy in Thyroid Patients
by: Pariya Phanachet, et al.
Published: (2023-07-01)

The utility of low-iodine diet in preparation for thyroid cancer therapy with radioactive iodine—A cohort study
by: Hongxiu Luo, et al.
Published: (2022-09-01)

REFRACTORY OF WELL-DIFFERENTIATED THYROID CANCER TO THE TREATMENT WITH RADIOACTIVE IODINE
by: P. O. Rumyantsev
Published: (2015-04-01)

Analysis of tumor recurrence factors of the patients with intermediate risk papillary thyroid carcinoma after radioactive iodine treatment
by: TANG Linglin, LI Li, LAI Yi, LIU Jianjun, ZHOU Xiang
Published: (2023-11-01)

Anaplastic Thyroid Carcinoma Following Radioactive Iodine Therapy for Graves' Disease
by: Sun Hwa Kim, et al.
Published: (2013-03-01)

Radioactive iodine-refractory differentiated thyroid cancer: an uncommon but challenging situation
by: Angelica Schmidt, et al.
Published: (2017-02-01)

Current Advances in Radioactive Iodine-Refractory Differentiated Thyroid Cancer
by: Fabio Volpe, et al.
Published: (2024-07-01)

Outcome of Radioactive Iodine Ablation/Treatment in Pathologically-Defined Low Risk of Recurrence Well-Differentiated Thyroid Carcinoma Patients
by: Pawana Pusuwan
Published: (2016-10-01)

Outcome of Radioactive Iodine Ablation/ Treatment in Pathologically-Defined Low Risk of Recurrence Well-Differentiated Thyroid Carcinoma Patients
by: Ajalaya Teyateeti, et al.
Published: (2016-09-01)

Low Iodine Diet for Preparation for Radioactive Iodine Therapy in Differentiated Thyroid Carcinoma in Korea
by: Jae Hoon Chung
Published: (2013-09-01)

Tyrosine Kinase Inhibitors for Radioactive Iodine Refractory Differentiated Thyroid Cancer
by: Christos Cortas, et al.
Published: (2023-12-01)

The effect of per os vs subcutaneous 123iodine administration on percentage thyroidal radioactive iodine uptake in normal cats
by: Kevin Cosford, et al.
Published: (2021-11-01)

Management of hyperthyroidism with radioactive iodine
by: T Premprapha, et al.
Published: (2006-08-01)

Iodine nutrition and papillary thyroid cancer
by: Xueqi Zhang, et al.
Published: (2022-10-01)

Predictors of response to Radioactive Iodine Therapy in Intermediate and high risk patients with papillary thyroid carcinoma
by: Azam Keshavarzi, et al.
Published: (2024-07-01)

The changes in complete blood count in thyroid cancer patients treated with radioactive iodine ablation therapy
by: Bircan Sönmez, et al.
Published: (2010-12-01)

The changes in complete blood count in thyroid cancer patients treated with radioactive iodine ablation therapy
by: Bircan Sönmez, et al.
Published: (2010-12-01)

Effect of Psychological Intervention on Differentiated Thyroid Cancer Patients in the Treatment with Radioactive Iodine
by: Liu YB, et al.
Published: (2023-03-01)

LENVATINIB IN TREATMENT OF RADIOACTIVE IODINE-REFRACTORY WELL-DIFFERENTIATED THYROID CARCINOMA
by: I. S. Romanov, et al.
Published: (2017-06-01)

Characteristics of exposure to radioactive iodine during a nuclear incident
by: Zaletel Katja, et al.
Published: (2024-10-01)

Comparing therapeutic outcomes: radioactive iodine therapy versus non-radioactive iodine therapy in differentiated thyroid cancer
by: Robert Aurelian Tiucă, et al.
Published: (2024-09-01)

Early-life gut microbiota in food allergic children and its impact on the development of allergic disease
by: Xiumei Yan, et al.
Published: (2023-11-01)

The effect of selenium supplementation on sonographic findings of salivary glands in papillary thyroid cancer (PTC) patients treated with radioactive iodine: study protocol for a double-blind, randomized, placebo-controlled clinical trial
by: Sepide Amini, et al.
Published: (2023-08-01)

Clinical experience in using lenvatinib in patients with progressive, radioactive iodine-refractory differentiated thyroid cancer
by: P. A. Isaev, et al.
Published: (2016-06-01)

Tracheal nodularity and paratracheal soft tissue nodule: post-radioactive iodine treatment changes with peculiar visual and pathologic findings in a case of metastatic follicular variant papillary thyroid carcinoma: a case report
by: Benjamin L. Sievers, et al.
Published: (2025-03-01)

Sarcoidosis mimicking metastatic thyroid cancer following radioactive iodine therapy
by: Zin W. Myint, et al.
Published: (2015-02-01)

Comparing the efficacy of thyroglobulin and thyroglobulin/ thyroid-stimulating hormone ratio models in predicting a successful response to radioactive iodine therapy
by: Yanli Ju, et al.
Published: (2023-01-01)

Visualization Analysis of Research Hotspots and Trends in Treatment of Radioactive Iodine Refractory Differentiated Thyroid Carcinoma
by: Xiaoxian ZENG, et al.
Published: (2025-02-01)

Association between radioactive iodine uptake and neutropenia in untreated Graves’ disease
by: Qian Yang, et al.
Published: (2023-01-01)

Reducing noise in radioactive iodine activity selection: the utility of an online clinical calculator
by: Ayanthi Wijewardene, et al.
Published: (2024-10-01)

Urinary iodine excretion after using povidone iodine or chlorhexidine gluconate for topical disinfectant in patients undergoing thyroidectomy due to thyroid carcinoma: When to do radio active iodine therapy?
by: Soheila Shokrollahi Yancheshmeh, et al.
Published: (2023-01-01)

Effect of liver dysfunction on outcome of radioactive iodine therapy for Graves’ disease
by: Yuyang Ze, et al.
Published: (2022-12-01)

Analyzing Serum Level Changes in Dehydroepiandrosterone Sulfate, Dihydrotestosterone, Progesterone, and Prolactin after Radioactive Iodine Treatment for Papillary Thyroid Carcinoma
by: Mehrosadat Alavi, et al.
Published: (2024-07-01)

Success Rate of Radioactive Iodine Ablation in Low-Risk of Recurrence Well-Differentiated Thyroid Carcinoma Patients
by: Ajalaya Teyateeti, et al.
Published: (2016-07-01)

Success Rate of Radioactive Iodine Ablation in Low-Risk of Recurrence Well-Differentiated Thyroid Carcinoma Patients
by: Pawana Pusuwan
Published: (2016-08-01)

The efficacy and safety in radioactive iodine refractory thyroid cancer patients treated with sorafenib
by: Yuanna Ling, et al.
Published: (2023-07-01)

Trends in radioactive iodine treatment after total thyroidectomy in Italy, 2001–2018
by: Luigino Dal Maso, et al.
Published: (2023-07-01)